A neuroscience mystery has been solved by using artificial intelligence (AI) to identify the electrical signatures of different types of brain neurons for the first time.
Professor Sultan Mahmud, Director of Healthcare for BT’s Enterprise unit, discusses how BT is redefining its healthcare ambitions through co-creating NHS-first solutions with its vanguard partners.
Clint Schick, Chief Executive, Strata Health UK, describes a software system that has made the manual process...digital – freeing up staff time & improving patient care.
PinPoint Data Science addresses the acute challenges of cancer diagnostics in the post-COVID NHS. Could their innovative machine learning platform be the low-cost, high-impact solution UK healthcare needs?
Rapidly scaling health-tech player in the emerging Pathology Computer Aided Diagnostics sector Deciphex uses digital pathology and AI to accelerate pathology diagnosis by improving productivity and patient outcome.
Shiao Fong Yee, Marketing Communications Manager at Novacyt Group, discusses the importance of rapid testing to differentiate between COVID-19 and other infections in light of facing winter respiratory viral challenges.
Brian Murphy, CSO of UK digital health firm Cumulus Neuroscience, explores how AI tools could transform drug development in the difficult area of cognitive disorders.
Dr Deborah Lee, Dr Fox Online Pharmacy, discusses a possible new treatment for endometriosis - the condition that impacts atleast 1.5 million women in the UK.
A new study estimates HIV disproportionately affects trans feminine women, with 20% of trans feminine individuals being positive with the virus, highlighting the need for prevention efforts and appropriate sex education.
Chaith Kondragunta, CEO at AIRA Matrix Private Limited, details Artificial Intelligence-based solutions that can positively impact prostate cancer outcomes.
Aarthi JanakiRaman, Research Director, Chemicals and Advanced Materials at TechVision, sheds light on food allergies and considers if this is an epidemic
A new study on HIV medication treatment discovered persistent disparities between sex and age, potentially subjecting women to worse HIV treatment outcomes on the drug dolutegravir.
